Overview

24-hr Intraocular Pressure Control With SIMBRINZA ®

Status:
Completed
Trial end date:
2017-01-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate differences between treatments in mean change from baseline in 24-hr intraocular pressure (IOP) at Week 4.
Phase:
Phase 4
Details
Lead Sponsor:
Alcon Research
Treatments:
Brimonidine Tartrate
Brinzolamide